Welcome to the May 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
-
Paper of the MonthEAN NewsResearchFeatured SliderResearch Papers of the Month: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis / Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
Our papers of the month for May are two papers present findings from recent trials evaluating the efficacy and safety of tolebrutinib in patients with multiple sclerosis. -
Executive PageAdvocacyBrain HealthEAN NewsFeatured SliderExecutive Page: If you do not communicate, you do not exist! A March full of meetings, summits and forums
EAN Communications Committee Chair, Matilde Leonardi, looks back on an extremely busy and productive period of communication activity for the EAN. -
Welcome to the April 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Intake of Red Meat in Relation to Dementia Risk and Cognitive Function in US Adults
Our Paper of the Month is a prospective cohort study conducted in the US, including participants from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). -
Executive PageEAN NewsFeatured SliderExecutive Page: New opportunities to learn for all neurologists!
EAN Education Committee Chair, Nathalie Nasr, provides an update on the full range of EAN learning opportunities. -
Welcome to the March 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsResearchFeatured Slider
Research Paper of the Month: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s disease in the UK
Our paper of the month for March is a phase 3 multicentre, double-blind, randomised trial investigating whether treatment with exenatide can slow the progression of Parkinson’s disease. -
Executive PageEAN NewsFeatured SliderExecutive Page: “on a Brain Mission” – EAN Treasurer on her first six months in office
EAN Treasurer, Jana Midelfart-Hoff reviews her "fantastic experience" in office over the last six months, representing the EAN and the Brain Health Mission on various levels -
Welcome to the February 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsFeatured Slider
Research Papers of the Month: Safety and efficacy of satralizumab/nipocalimab in patients with generalised myasthenia gravis
For February we have selected two co-papers of the month, each of which examines the safety and efficacy of a specific drug in the treatment of patients with generalised myasthenia gravis. -
Executive PageEAN NewsEAN Congress newsFeatured SliderExecutive Page: Submit, register, and join us for our 11th Congress in Helsinki!
EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved! -
Welcome to the first edition of the President’s Corner, a new article series in which the EAN President, Elena Moro, answers your questions!
-
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease
Our paper of the month compares drug prescription prior to the clinical onset of sporadic Creutzfeldt-Jakob disease in patients versus matched controls aiming to uncover potential risk or protective factors. -
Executive PageAdvocacyBrain HealthEAN NewsEAN Congress newsFeatured SliderExecutive Page: EAN President reviews a milestone year and looks ahead to exciting plans for 2025
EAN President, Prof. Elena Moro, looks back at some highlights of a successful 10th anniversary year for the EAN, and ahead to some exciting plans for 2025.